Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer's disease
- PMID: 29183770
- DOI: 10.1016/j.phrs.2017.11.028
Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer's disease
Abstract
Alzheimer's disease (AD) is regarded as a progressive and devastating neurodegenerative disorder. In aged individuals, it is the most prevalent cause of dementia and is characterized by gradual loss of cognitive functions. In the last decade, numerous research works were undertaken to investigate the pathogenesis of AD. Although the etiology of AD is still not clear, several histopathological studies confirm prominent changes in the AD affected brains. The major changes include the formation of senile plaques and neurofibrillary tangles primarily owing to the deposition of amyloid β plaques (Aβ) and hyper-phosphorylation of tau protein. Disruption of the redox homeostasis in the brain is a major triggering factor for the development of such pathophysiological conditions. Chemical formulations usually act by inhibiting activities of the enzymes responsible for the development of AD. But with time, these pharmacotherapies develop many side effects including toxicity in different organs. Recent researches are henceforth focused on the identification of novel therapeutic molecules from the nature's basket. This review aims to emphasize the therapeutic effects and regulation of molecular targets of different natural products such as curcumin, resveratrol, genistein and others. These prophylactic multipotent natural compounds have the potency to interfere with the formation as well as deposition of the Aβ peptides. These natural compounds have also been found in modulating different intracellular signalling molecules and enzymes including β-secretase and γ-secretase. This review article is expected to be helpful in understanding the recent progress in natural product research as a therapeutic approach in amelioration and/or delaying the detrimental effects of AD.
Keywords: Alzheimer’s disease; Amyloid β; Naturally occurring bioactive molecule; Oxidative stress; Reactive oxygen species; Tau hyper- phosphorylation.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
-
[Alzheimer's disease: new prospects in therapy and applied experimental models].Postepy Hig Med Dosw (Online). 2008 Aug 5;62:372-92. Postepy Hig Med Dosw (Online). 2008. PMID: 18688208 Review. Polish.
-
The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.Acc Chem Res. 2014 Aug 19;47(8):2475-82. doi: 10.1021/ar500152x. Epub 2014 Jul 31. Acc Chem Res. 2014. PMID: 25080056
-
Alzheimer's disease pathogenesis and therapeutic interventions.J Clin Neurosci. 2004 Jun;11(5):456-67. doi: 10.1016/j.jocn.2003.12.007. J Clin Neurosci. 2004. PMID: 15177383 Review.
-
Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.Biotechnol Adv. 2017 Mar-Apr;35(2):178-216. doi: 10.1016/j.biotechadv.2016.12.005. Epub 2016 Dec 30. Biotechnol Adv. 2017. PMID: 28043897 Review.
Cited by
-
Nosustrophine: An Epinutraceutical Bioproduct with Effects on DNA Methylation, Histone Acetylation and Sirtuin Expression in Alzheimer's Disease.Pharmaceutics. 2022 Nov 12;14(11):2447. doi: 10.3390/pharmaceutics14112447. Pharmaceutics. 2022. PMID: 36432638 Free PMC article.
-
Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes.Cancers (Basel). 2020 Dec 18;12(12):3822. doi: 10.3390/cancers12123822. Cancers (Basel). 2020. PMID: 33352869 Free PMC article. Review.
-
Neuroprotective Mechanisms of Resveratrol in Alzheimer's Disease: Role of SIRT1.Oxid Med Cell Longev. 2018 Oct 30;2018:8152373. doi: 10.1155/2018/8152373. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30510627 Free PMC article. Review.
-
Resveratrol Abrogates Hypoxia-Induced Up-Regulation of Exosomal Amyloid-β Partially by Inhibiting CD147.Neurochem Res. 2019 May;44(5):1113-1126. doi: 10.1007/s11064-019-02742-3. Epub 2019 Feb 15. Neurochem Res. 2019. PMID: 30771155
-
Role of soy lecithin combined with soy isoflavone on cerebral blood flow in rats of cognitive impairment and the primary screening of its optimum combination.Nutr Res Pract. 2023 Apr;17(2):371-385. doi: 10.4162/nrp.2023.17.2.371. Epub 2022 Oct 4. Nutr Res Pract. 2023. PMID: 37009142 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical